Lake Hills Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Buy
100,636
+8,663
+9% +$1.17M 7.24% 3
2026
Q1
$11.7M Buy
+91,973
New +$11.5M 6.57% 3
2024
Q3
Sell
-22,360
Closed -$2.07M 57
2024
Q2
$2.07M Buy
+22,360
New +$2M 1.49% 26

Other funds holding XBI

Lake Hills Wealth Management's XBI Position: Q2 2026 in Review

Lake Hills Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.4% in Q2 2026, buying an estimated $1.17M and bringing the position to 100,636 shares worth $15.9M. The position accounts for 7.24% of the portfolio, ranked #3.

Lake Hills Wealth Management first reported a position in XBI in Q2 2024 and has held it in 3 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Lake Hills Wealth Management held 100,636 shares of State Street SPDR S&P Biotech ETF worth $15.9M as of Q2 2026.
  • Lake Hills Wealth Management bought 8,663 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.17M.
  • State Street SPDR S&P Biotech ETF made up 7.24% of Lake Hills Wealth Management's portfolio in Q2 2026, its #3 holding.
  • Lake Hills Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 3 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Lake Hills Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.